Targeting an antioxidant to mitochondria decreases cardiac ischemia-reperfusion injury
Mitochondrial oxidative damage contributes to a wide range of pathologies, including cardiovascular disorders and neurodegenerative diseases. Therefore, protecting mitochondria from oxidative damage should be an effective therapeutic strategy. However, conventional antioxidants have limited efficacy...
Saved in:
| Published in | The FASEB journal Vol. 19; no. 9; pp. 1088 - 1095 |
|---|---|
| Main Authors | , , , , , , |
| Format | Journal Article |
| Language | English |
| Published |
United States
01.07.2005
|
| Subjects | |
| Online Access | Get more information |
Cover
Loading…
| Abstract | Mitochondrial oxidative damage contributes to a wide range of pathologies, including cardiovascular disorders and neurodegenerative diseases. Therefore, protecting mitochondria from oxidative damage should be an effective therapeutic strategy. However, conventional antioxidants have limited efficacy due to the difficulty of delivering them to mitochondria in situ. To overcome this problem, we developed mitochondria-targeted antioxidants, typified by MitoQ, which comprises a lipophilic triphenylphosphonium (TPP) cation covalently attached to a ubiquinol antioxidant. Driven by the large mitochondrial membrane potential, the TPP cation concentrates MitoQ several hundred-fold within mitochondria, selectively preventing mitochondrial oxidative damage. To test whether MitoQ was active in vivo, we chose a clinically relevant form of mitochondrial oxidative damage: cardiac ischemia-reperfusion injury. Feeding MitoQ to rats significantly decreased heart dysfunction, cell death, and mitochondrial damage after ischemia-reperfusion. This protection was due to the antioxidant activity of MitoQ within mitochondria, as an untargeted antioxidant was ineffective and accumulation of the TPP cation alone gave no protection. Therefore, targeting antioxidants to mitochondria in vivo is a promising new therapeutic strategy in the wide range of human diseases such as Parkinson's disease, diabetes, and Friedreich's ataxia where mitochondrial oxidative damage underlies the pathology.--Adlam, V. J., Harrison, J. C., Porteous, C. M., James, A. M., Smith, R. A. J., Murphy, M. P., Sammut, I. A. Targeting an antioxidant to mitochondria decreases cardiac ischemia-reperfusion injury. |
|---|---|
| AbstractList | Mitochondrial oxidative damage contributes to a wide range of pathologies, including cardiovascular disorders and neurodegenerative diseases. Therefore, protecting mitochondria from oxidative damage should be an effective therapeutic strategy. However, conventional antioxidants have limited efficacy due to the difficulty of delivering them to mitochondria in situ. To overcome this problem, we developed mitochondria-targeted antioxidants, typified by MitoQ, which comprises a lipophilic triphenylphosphonium (TPP) cation covalently attached to a ubiquinol antioxidant. Driven by the large mitochondrial membrane potential, the TPP cation concentrates MitoQ several hundred-fold within mitochondria, selectively preventing mitochondrial oxidative damage. To test whether MitoQ was active in vivo, we chose a clinically relevant form of mitochondrial oxidative damage: cardiac ischemia-reperfusion injury. Feeding MitoQ to rats significantly decreased heart dysfunction, cell death, and mitochondrial damage after ischemia-reperfusion. This protection was due to the antioxidant activity of MitoQ within mitochondria, as an untargeted antioxidant was ineffective and accumulation of the TPP cation alone gave no protection. Therefore, targeting antioxidants to mitochondria in vivo is a promising new therapeutic strategy in the wide range of human diseases such as Parkinson's disease, diabetes, and Friedreich's ataxia where mitochondrial oxidative damage underlies the pathology.--Adlam, V. J., Harrison, J. C., Porteous, C. M., James, A. M., Smith, R. A. J., Murphy, M. P., Sammut, I. A. Targeting an antioxidant to mitochondria decreases cardiac ischemia-reperfusion injury. Mitochondrial oxidative damage contributes to a wide range of pathologies, including cardiovascular disorders and neurodegenerative diseases. Therefore, protecting mitochondria from oxidative damage should be an effective therapeutic strategy. However, conventional antioxidants have limited efficacy due to the difficulty of delivering them to mitochondria in situ. To overcome this problem, we developed mitochondria-targeted antioxidants, typified by MitoQ, which comprises a lipophilic triphenylphosphonium (TPP) cation covalently attached to a ubiquinol antioxidant. Driven by the large mitochondrial membrane potential, the TPP cation concentrates MitoQ several hundred-fold within mitochondria, selectively preventing mitochondrial oxidative damage. To test whether MitoQ was active in vivo, we chose a clinically relevant form of mitochondrial oxidative damage: cardiac ischemia-reperfusion injury. Feeding MitoQ to rats significantly decreased heart dysfunction, cell death, and mitochondrial damage after ischemia-reperfusion. This protection was due to the antioxidant activity of MitoQ within mitochondria, as an untargeted antioxidant was ineffective and accumulation of the TPP cation alone gave no protection. Therefore, targeting antioxidants to mitochondria in vivo is a promising new therapeutic strategy in the wide range of human diseases such as Parkinson's disease, diabetes, and Friedreich's ataxia where mitochondrial oxidative damage underlies the pathology. |
| Author | Sammut, Ivan A James, Andrew M Adlam, Victoria J Murphy, Michael P Smith, Robin A. J Porteous, Carolyn M Harrison, Joanne C |
| Author_xml | – sequence: 1 fullname: Adlam, Victoria J – sequence: 2 fullname: Harrison, Joanne C – sequence: 3 fullname: Porteous, Carolyn M – sequence: 4 fullname: James, Andrew M – sequence: 5 fullname: Smith, Robin A. J – sequence: 6 fullname: Murphy, Michael P – sequence: 7 fullname: Sammut, Ivan A |
| BackLink | https://www.ncbi.nlm.nih.gov/pubmed/15985532$$D View this record in MEDLINE/PubMed |
| BookMark | eNo1kE1LAzEYhIMo9kOPXnX_wNY3eZs0OUrxCyoebL0ub5Nsm-JuSrIF--9dqcLAcxmGmRmx8za2nrEbDhMORt3XuwnIEmdc29icsSGXCKXSCs7ZELQRpVKoB2yU8w4AOHB1yQZcGi0liiH7XFLa-C60m4LaXl2I38H1LLpYNKGLdhtblwIVztvkKftcWEoukC1CtlvfBCqT3_tUH3KIbRHa3SEdr9hFTV_ZX_9xzFZPj8v5S7l4f36dPyxKKxHfSlxrrzVyq7DW6Pp6wiqScq2sIQ7oNZ8K5UAab6cKsHZUKxJTNIhmRijG7PaUuz-sG--qfQoNpWP1P7A33J0MNcWKNinkavUhgOPvFdwAiB8BZV5L |
| CitedBy_id | crossref_primary_10_1016_j_yjmcc_2009_05_013 crossref_primary_10_1007_s11897_017_0347_7 crossref_primary_10_1002_1873_3468_12319 crossref_primary_10_1016_j_bbadis_2005_10_007 crossref_primary_10_1016_j_pharmthera_2021_108053 crossref_primary_10_1016_j_bbadis_2005_10_001 crossref_primary_10_1360_SSV_2021_0366 crossref_primary_10_3389_fcell_2022_841523 crossref_primary_10_1016_j_ajem_2012_01_001 crossref_primary_10_1016_j_redox_2014_05_006 crossref_primary_10_1016_j_mad_2005_12_009 crossref_primary_10_1002_jcsm_12405 crossref_primary_10_1007_s00424_007_0328_x crossref_primary_10_1016_j_bbadis_2018_05_018 crossref_primary_10_1016_j_bbrc_2018_10_058 crossref_primary_10_1016_j_biopha_2018_11_128 crossref_primary_10_1016_j_freeradbiomed_2011_08_022 crossref_primary_10_1002_ddr_21911 crossref_primary_10_1155_2015_864946 crossref_primary_10_3390_ijms22157964 crossref_primary_10_1016_j_bbadis_2020_165967 crossref_primary_10_3390_ijms22084261 crossref_primary_10_1152_ajprenal_00591_2014 crossref_primary_10_1161_01_RES_0000250430_62775_99 crossref_primary_10_1016_j_redox_2015_07_008 crossref_primary_10_2174_1568026622666220405121643 crossref_primary_10_3390_ijms26051917 crossref_primary_10_1016_j_neuropharm_2011_07_008 crossref_primary_10_1016_j_jconrel_2014_06_038 crossref_primary_10_1523_JNEUROSCI_0552_11_2011 crossref_primary_10_1038_nrcardio_2017_102 crossref_primary_10_1016_j_ajpath_2011_03_017 crossref_primary_10_4155_tde_10_8 crossref_primary_10_1016_j_jhazmat_2015_08_046 crossref_primary_10_1007_s11897_023_00589_y crossref_primary_10_1038_nrd_2018_174 crossref_primary_10_1039_C9CC04585F crossref_primary_10_1093_cvr_cvs111 crossref_primary_10_1371_journal_pone_0167300 crossref_primary_10_1016_j_bbadis_2010_06_011 crossref_primary_10_1161_CIRCRESAHA_112_265660 crossref_primary_10_1007_s10545_010_9162_y crossref_primary_10_1093_cvr_cvq195 crossref_primary_10_1016_j_bmc_2010_01_019 crossref_primary_10_1113_jphysiol_2013_268680 crossref_primary_10_1016_j_biocel_2016_06_015 crossref_primary_10_2217_nnm_11_44 crossref_primary_10_1101_cshperspect_a041199 crossref_primary_10_1186_s40001_024_02181_z crossref_primary_10_15252_emmm_201505748 crossref_primary_10_1515_hsz_2021_0121 crossref_primary_10_1042_BJ20100308 crossref_primary_10_1039_C8TX00160J crossref_primary_10_1111_acel_13269 crossref_primary_10_1007_s11883_012_0237_0 crossref_primary_10_1016_j_addr_2015_12_024 crossref_primary_10_1126_science_1250256 crossref_primary_10_1089_ars_2009_2531 crossref_primary_10_1016_j_freeradbiomed_2013_03_018 crossref_primary_10_1089_ars_2007_2008 crossref_primary_10_1111_j_1365_2796_2008_02058_x crossref_primary_10_1016_j_pneurobio_2016_06_006 crossref_primary_10_1134_S0006297911120108 crossref_primary_10_1016_j_yexcr_2019_111774 crossref_primary_10_1042_CS20110643 crossref_primary_10_1096_fj_07_102541 crossref_primary_10_1093_cvr_cvz183 crossref_primary_10_1007_s00421_020_04396_4 crossref_primary_10_1155_2019_8267234 crossref_primary_10_1155_2022_9530007 crossref_primary_10_1016_j_bbadis_2020_165768 crossref_primary_10_1161_CIRCRESAHA_111_255216 crossref_primary_10_1152_ajpheart_01048_2007 crossref_primary_10_1152_physrev_00036_2017 crossref_primary_10_1016_j_redox_2012_11_009 crossref_primary_10_3390_antiox3030472 crossref_primary_10_1161_CIRCRESAHA_119_316306 crossref_primary_10_1016_j_mito_2021_04_008 crossref_primary_10_3389_fnagi_2021_617588 crossref_primary_10_1089_ars_2013_5594 crossref_primary_10_3390_ijms16036312 crossref_primary_10_1007_s00232_008_9108_6 crossref_primary_10_1093_cvr_cvr349 crossref_primary_10_1111_bph_12650 crossref_primary_10_1161_CIRCRESAHA_113_302095 crossref_primary_10_1007_s00018_021_03773_2 crossref_primary_10_1155_2016_1971452 crossref_primary_10_1164_rccm_200410_1346OC crossref_primary_10_1016_j_yjmcc_2007_01_010 crossref_primary_10_1016_j_neuropharm_2018_07_014 crossref_primary_10_1249_mss_0b013e3180d099c1 crossref_primary_10_1016_j_yjmcc_2011_02_005 crossref_primary_10_1126_scisignal_abn6875 crossref_primary_10_1016_j_yjmcc_2014_08_018 crossref_primary_10_1111_bcpt_13500 crossref_primary_10_1097_TA_0000000000000533 crossref_primary_10_1016_j_jconrel_2012_01_009 crossref_primary_10_1080_14728222_2018_1439921 crossref_primary_10_1152_physiol_00030_2013 crossref_primary_10_1124_jpet_112_195586 crossref_primary_10_1016_j_actbio_2019_10_006 crossref_primary_10_3390_ijms222111939 crossref_primary_10_1016_j_cclet_2022_02_047 crossref_primary_10_1038_s41598_020_58071_x crossref_primary_10_3389_fphys_2015_00347 crossref_primary_10_1586_ecp_09_41 crossref_primary_10_1111_bph_12405 crossref_primary_10_1152_physrev_00031_2007 crossref_primary_10_1016_j_freeradbiomed_2008_09_003 crossref_primary_10_1016_j_hfc_2012_06_001 crossref_primary_10_1016_j_arr_2020_101250 crossref_primary_10_1016_j_pharmthera_2012_01_004 crossref_primary_10_1152_japplphysiol_00418_2017 crossref_primary_10_1016_j_bbadis_2012_07_009 crossref_primary_10_1016_j_freeradbiomed_2014_12_018 crossref_primary_10_1152_ajpheart_00593_2009 crossref_primary_10_1016_j_freeradbiomed_2009_08_019 crossref_primary_10_1161_HYPERTENSIONAHA_109_130351 crossref_primary_10_1002_ddrr_109 crossref_primary_10_1042_BST0380841 crossref_primary_10_1016_j_bbagen_2013_02_005 crossref_primary_10_1007_s10741_016_9531_1 crossref_primary_10_3389_fphar_2024_1433961 crossref_primary_10_1371_journal_pone_0053272 crossref_primary_10_3390_molecules16119194 crossref_primary_10_1124_jpet_110_176743 crossref_primary_10_3389_fcell_2021_636295 crossref_primary_10_1039_c2tx20016c crossref_primary_10_1016_j_bbabio_2008_12_008 crossref_primary_10_1016_j_bbadis_2013_09_005 crossref_primary_10_1016_j_bbadis_2013_09_007 crossref_primary_10_1016_j_bbamcr_2016_02_012 crossref_primary_10_1113_JP277306 crossref_primary_10_1007_BF03190873 crossref_primary_10_1124_jpet_106_114769 crossref_primary_10_3390_ijms14059126 crossref_primary_10_1007_s11897_022_00539_0 crossref_primary_10_1161_ATVBAHA_111_241802 crossref_primary_10_1016_j_biopha_2023_116020 crossref_primary_10_1016_j_bbadis_2016_11_010 crossref_primary_10_3390_antiox11030585 crossref_primary_10_1002_em_20554 crossref_primary_10_1002_med_21732 crossref_primary_10_1016_j_yjmcc_2013_05_010 crossref_primary_10_1161_CIRCRESAHA_118_310082 crossref_primary_10_1016_j_mito_2012_10_015 crossref_primary_10_1016_j_jconrel_2015_06_037 crossref_primary_10_3390_ijms141123011 crossref_primary_10_1097_01_CCM_0000279192_96303_E7 crossref_primary_10_1016_j_biotechadv_2012_09_005 crossref_primary_10_1016_j_mam_2019_100836 crossref_primary_10_1152_ajpheart_00947_2007 crossref_primary_10_1161_JAHA_116_003697 crossref_primary_10_1073_pnas_1821022116 crossref_primary_10_1007_s12576_014_0333_8 crossref_primary_10_1038_s12276_019_0355_7 crossref_primary_10_1016_j_exger_2022_111711 crossref_primary_10_1007_s00232_015_9818_5 crossref_primary_10_1089_ars_2011_3969 crossref_primary_10_1111_j_1442_200X_2008_02705_x crossref_primary_10_1097_MAO_0000000000000192 crossref_primary_10_1016_j_freeradbiomed_2007_12_036 crossref_primary_10_1016_j_ijpharm_2017_02_013 crossref_primary_10_1134_S000629790812002X crossref_primary_10_1155_2021_6626484 crossref_primary_10_3390_brainsci10070449 crossref_primary_10_1016_j_tem_2007_04_004 crossref_primary_10_1016_j_freeradbiomed_2013_05_014 crossref_primary_10_1042_BST20190305 crossref_primary_10_1016_j_yjmcc_2011_09_018 crossref_primary_10_1016_j_bbamcr_2011_01_009 crossref_primary_10_15252_emmm_201809456 crossref_primary_10_1016_j_freeradbiomed_2012_05_028 crossref_primary_10_3748_wjg_v20_i39_14205 crossref_primary_10_1111_apha_13430 crossref_primary_10_1016_j_brainres_2008_12_027 crossref_primary_10_1016_j_healun_2015_05_007 crossref_primary_10_1152_ajpheart_00028_2018 crossref_primary_10_1159_000103747 crossref_primary_10_1039_C3RA46172F crossref_primary_10_3390_biomedicines9020216 crossref_primary_10_1124_jpet_108_143479 crossref_primary_10_1211_jpp_59_4_0004 crossref_primary_10_3390_cells13040353 crossref_primary_10_1016_j_chembiol_2016_06_012 crossref_primary_10_1039_c3tb20884b crossref_primary_10_1155_JBB_2006_31372 crossref_primary_10_1093_cvr_cvad088 crossref_primary_10_1155_2021_6614009 crossref_primary_10_1152_physrev_00058_2021 crossref_primary_10_1007_s13239_018_0368_8 crossref_primary_10_1021_acsomega_4c02725 crossref_primary_10_1016_j_bbrc_2013_10_063 crossref_primary_10_1016_j_taap_2018_01_003 crossref_primary_10_1155_2022_2213503 crossref_primary_10_3389_fcell_2022_1082095 crossref_primary_10_1152_ajplung_00365_2017 crossref_primary_10_1517_17425255_2_1_71 crossref_primary_10_3390_ijms160818185 crossref_primary_10_1007_s11883_012_0266_8 crossref_primary_10_1089_ars_2019_7928 crossref_primary_10_1042_BJ20080063 crossref_primary_10_1146_annurev_pharmtox_47_120505_105110 crossref_primary_10_1016_j_metabol_2023_155626 crossref_primary_10_1124_jpet_109_153213 crossref_primary_10_1089_ars_2014_5952 crossref_primary_10_1016_j_freeradbiomed_2007_12_029 crossref_primary_10_1016_j_ejmech_2019_07_060 crossref_primary_10_1152_ajprenal_00278_2014 crossref_primary_10_3390_antiox8110514 crossref_primary_10_1021_cb400821p crossref_primary_10_1161_CIRCHEARTFAILURE_117_004658 crossref_primary_10_1161_CIRCULATIONAHA_110_939959 crossref_primary_10_1042_BJ20101957 crossref_primary_10_1093_jas_skae161 crossref_primary_10_1007_s12012_009_9055_1 crossref_primary_10_1016_j_msec_2019_109824 crossref_primary_10_1161_CIRCULATIONAHA_121_056929 crossref_primary_10_1007_s10863_009_9206_x crossref_primary_10_1002_wnan_1305 crossref_primary_10_1016_j_ejphar_2011_11_036 crossref_primary_10_1002_mds_23148 crossref_primary_10_1016_j_cbpc_2021_109111 crossref_primary_10_1089_ars_2007_1879 crossref_primary_10_1681_ASN_2012121216 crossref_primary_10_1152_physrev_00013_2006 crossref_primary_10_1093_jas_skae250 crossref_primary_10_1093_bja_aer093 crossref_primary_10_1002_jcp_25349 crossref_primary_10_1155_2014_604685 crossref_primary_10_1155_2020_8878172 crossref_primary_10_1016_j_bbabio_2008_03_029 crossref_primary_10_1089_ars_2015_6393 crossref_primary_10_1089_ars_2007_1865 crossref_primary_10_1038_s41569_018_0074_0 crossref_primary_10_1002_mnfr_200700402 crossref_primary_10_1111_j_1749_6632_2010_05627_x crossref_primary_10_1161_CIRCRESAHA_116_305432 crossref_primary_10_1007_s10741_007_9028_z crossref_primary_10_1080_10409238_2020_1828258 crossref_primary_10_1002_med_21332 crossref_primary_10_1016_j_bbamcr_2018_12_012 crossref_primary_10_1016_j_bbabio_2017_05_005 crossref_primary_10_1016_j_bbagen_2010_06_001 crossref_primary_10_1039_C4OB01981D crossref_primary_10_1089_ars_2015_6260 crossref_primary_10_3390_pharmaceutics12111122 crossref_primary_10_1016_j_freeradbiomed_2018_09_019 crossref_primary_10_1016_j_biocel_2009_02_015 crossref_primary_10_1161_CIRCRESAHA_110_232306 crossref_primary_10_1208_aapsj080362 crossref_primary_10_1096_fj_05_4692com crossref_primary_10_2174_1381612827666210125155821 crossref_primary_10_1016_j_freeradbiomed_2007_02_006 crossref_primary_10_1186_s12933_017_0604_9 crossref_primary_10_1161_CIRCRESAHA_116_303584 crossref_primary_10_1371_journal_pone_0139416 crossref_primary_10_3109_10717544_2014_993747 crossref_primary_10_1016_j_trsl_2018_04_005 crossref_primary_10_1016_j_bbabio_2010_01_032 crossref_primary_10_1016_j_freeradbiomed_2022_12_007 crossref_primary_10_1038_s44222_025_00293_7 crossref_primary_10_1002_adsc_200800542 crossref_primary_10_1016_j_redox_2015_04_008 crossref_primary_10_3390_antiox10020163 crossref_primary_10_1186_s12986_015_0044_z crossref_primary_10_1002_hep_24377 crossref_primary_10_1016_j_freeradbiomed_2021_03_046 crossref_primary_10_1093_labmed_lmaa063 crossref_primary_10_1161_CIRCRESAHA_115_306569 crossref_primary_10_1517_17425247_5_8_879 crossref_primary_10_2165_11317870_000000000_00000 crossref_primary_10_3390_antiox10091377 crossref_primary_10_3390_molecules15031196 crossref_primary_10_1074_jbc_M502391200 crossref_primary_10_1021_ar700135m crossref_primary_10_1016_j_ejpb_2007_06_010 crossref_primary_10_1016_j_biopha_2023_115271 crossref_primary_10_1111_j_1600_079X_2009_00663_x crossref_primary_10_1016_j_carpath_2010_06_011 crossref_primary_10_1155_2019_9617087 crossref_primary_10_1016_j_pharmthera_2011_11_004 crossref_primary_10_1093_cvr_cvac134 crossref_primary_10_1111_jcmm_15279 crossref_primary_10_1186_1741_7015_11_178 crossref_primary_10_1093_toxsci_kfn132 crossref_primary_10_1016_j_tet_2015_09_014 crossref_primary_10_1089_ars_2010_3586 crossref_primary_10_4049_jimmunol_2101166 crossref_primary_10_1111_j_1600_079X_2007_00488_x crossref_primary_10_1161_CIRCRESAHA_107_167072 crossref_primary_10_1016_j_pharmthera_2013_07_011 crossref_primary_10_1016_j_jconrel_2017_01_013 crossref_primary_10_1136_lupus_2020_000387 crossref_primary_10_1111_jcmm_15043 crossref_primary_10_1196_annals_1427_003 crossref_primary_10_1186_s13046_022_02447_6 crossref_primary_10_1016_j_yjmcc_2009_09_004 crossref_primary_10_1586_17469899_2_2_237 crossref_primary_10_1016_j_freeradbiomed_2012_07_010 crossref_primary_10_1186_2251_6581_13_60 crossref_primary_10_1038_sj_bjp_0707288 crossref_primary_10_1089_ars_2011_4179 crossref_primary_10_3390_ijms242417215 crossref_primary_10_1016_j_bbabio_2008_12_017 crossref_primary_10_1073_pnas_0706585104 crossref_primary_10_1089_ars_2007_1929 crossref_primary_10_1155_2020_8837893 crossref_primary_10_2174_1389203720666190830163735 crossref_primary_10_3389_fimmu_2018_01605 crossref_primary_10_1016_j_biomaterials_2012_03_032 crossref_primary_10_1152_ajpcell_00322_2010 crossref_primary_10_1007_s10522_013_9454_3 crossref_primary_10_3389_ftox_2022_747508 crossref_primary_10_1016_j_freeradbiomed_2010_08_018 crossref_primary_10_1089_ars_2010_3309 crossref_primary_10_1016_j_lfs_2015_09_022 crossref_primary_10_3390_ijms17010047 crossref_primary_10_1016_j_yjmcc_2014_03_011 crossref_primary_10_1089_ars_2010_3685 crossref_primary_10_1002_1873_3468_12943 crossref_primary_10_1139_apnm_2017_0213 crossref_primary_10_1021_acs_molpharmaceut_6b00237 crossref_primary_10_1021_tx500032e crossref_primary_10_1089_ars_2015_6294 crossref_primary_10_1002_cbic_200800162 crossref_primary_10_1089_hum_2008_090 crossref_primary_10_1155_2016_2950503 crossref_primary_10_1186_cc9098 crossref_primary_10_1146_annurev_pharmtox_010715_103155 crossref_primary_10_3109_10799893_2013_822887 crossref_primary_10_5124_jkma_2009_52_10_1007 crossref_primary_10_1371_journal_pone_0048590 crossref_primary_10_1007_s00018_015_1950_y crossref_primary_10_1007_s11095_013_1111_7 crossref_primary_10_1074_jbc_M110_186643 crossref_primary_10_3389_fnmol_2019_00088 crossref_primary_10_1155_2015_189863 crossref_primary_10_1016_j_ajpath_2018_07_027 crossref_primary_10_12997_jla_2019_8_1_26 crossref_primary_10_1016_j_bbabio_2012_02_013 crossref_primary_10_1111_cmi_12787 crossref_primary_10_1152_ajpregu_90902_2008 crossref_primary_10_1093_bja_aew267 crossref_primary_10_1161_CIRCULATIONAHA_110_003418 crossref_primary_10_3389_fcvm_2021_774619 crossref_primary_10_1134_S0006297910020045 crossref_primary_10_1038_npp_2015_341 crossref_primary_10_1002_cbdv_202200445 crossref_primary_10_1097_01_sla_0000236626_57752_8e crossref_primary_10_1172_JCI184134 crossref_primary_10_1152_ajpheart_00203_2011 crossref_primary_10_2147_IJN_S240301 crossref_primary_10_1016_j_freeradbiomed_2010_12_009 crossref_primary_10_1016_j_bbabio_2015_07_009 crossref_primary_10_1074_jbc_M611463200 crossref_primary_10_1021_acs_bioconjchem_0c00470 crossref_primary_10_3109_08982104_2015_1022557 crossref_primary_10_1016_j_mad_2012_01_005 crossref_primary_10_3390_antiox13070788 crossref_primary_10_3390_cells11111855 crossref_primary_10_1155_2016_8254942 crossref_primary_10_1016_j_mvr_2024_104713 crossref_primary_10_1161_CIRCRESAHA_118_312708 crossref_primary_10_1007_s00232_013_9540_0 crossref_primary_10_1016_j_jacc_2012_08_1021 crossref_primary_10_1093_toxsci_kfx218 crossref_primary_10_1002_jcp_20711 crossref_primary_10_1111_j_1742_7843_2012_00856_x crossref_primary_10_3390_ijms24043739 crossref_primary_10_1021_bm500243m crossref_primary_10_1111_j_1478_3231_2010_02250_x crossref_primary_10_1523_JNEUROSCI_0823_07_2007 crossref_primary_10_1161_CIRCULATIONAHA_110_978528 crossref_primary_10_1016_j_freeradbiomed_2006_09_006 crossref_primary_10_1134_S000629791912006X crossref_primary_10_1016_j_freeradbiomed_2009_10_039 crossref_primary_10_1016_j_toxlet_2010_04_013 crossref_primary_10_1007_s00232_015_9833_6 crossref_primary_10_1016_j_scitotenv_2019_134994 crossref_primary_10_1007_s00395_013_0358_9 crossref_primary_10_1016_j_lfs_2016_09_013 crossref_primary_10_1097_HJH_0000000000000054 crossref_primary_10_1002_cbf_3587 crossref_primary_10_1016_j_pmatsci_2019_100599 crossref_primary_10_1097_MAO_0000000000000517 crossref_primary_10_1039_C8TX00060C crossref_primary_10_1164_rccm_201412_2259LE crossref_primary_10_1016_j_bcp_2007_05_019 crossref_primary_10_1016_j_cellsig_2021_110153 crossref_primary_10_3390_ijms19020417 crossref_primary_10_1016_j_mad_2010_06_002 crossref_primary_10_1371_journal_pone_0051553 crossref_primary_10_1096_fj_201900708R crossref_primary_10_3389_fcvm_2022_945142 crossref_primary_10_1093_jpp_rgac093 crossref_primary_10_1042_BJ20060919 crossref_primary_10_1016_j_nano_2018_12_014 crossref_primary_10_1016_j_bbabio_2022_148947 crossref_primary_10_1007_s11010_007_9520_8 crossref_primary_10_1016_j_mito_2011_07_004 crossref_primary_10_1016_j_ebiom_2020_102884 crossref_primary_10_1186_2046_2395_3_6 crossref_primary_10_1161_CIRCRESAHA_123_323882 crossref_primary_10_1016_j_freeradbiomed_2020_04_005 crossref_primary_10_1016_j_mito_2007_02_007 crossref_primary_10_1038_s42003_020_01440_z crossref_primary_10_1007_s11172_020_2787_6 crossref_primary_10_1016_j_yjmcc_2009_02_021 crossref_primary_10_1016_j_mito_2011_08_004 crossref_primary_10_1152_physrev_00024_2007 crossref_primary_10_1213_ANE_0000000000001773 crossref_primary_10_1016_j_freeradbiomed_2018_01_024 crossref_primary_10_1007_s12576_015_0365_8 crossref_primary_10_1515_jbcpp_2019_0063 crossref_primary_10_3390_molecules200814487 crossref_primary_10_1016_j_freeradbiomed_2021_05_013 crossref_primary_10_1007_s11010_007_9410_0 crossref_primary_10_1080_10715762_2025_2450504 crossref_primary_10_1093_hmg_ddq467 crossref_primary_10_3390_ijms24098209 crossref_primary_10_1007_s00232_017_9947_0 crossref_primary_10_1089_ars_2007_1892 crossref_primary_10_1021_acs_joc_8b02528 crossref_primary_10_3390_biom13091409 crossref_primary_10_1016_S1131_3587_11_15008_6 crossref_primary_10_1016_j_ceca_2022_102565 crossref_primary_10_1016_j_freeradbiomed_2018_01_012 crossref_primary_10_2217_fca_2017_0012 crossref_primary_10_3390_ijms20102386 crossref_primary_10_1038_s41598_019_46182_z crossref_primary_10_1016_j_chemosphere_2017_06_091 crossref_primary_10_1021_jo702355c crossref_primary_10_1113_JP273609 crossref_primary_10_2174_1566523220999200726225457 crossref_primary_10_1042_BST20160108 crossref_primary_10_1183_13993003_01024_2017 crossref_primary_10_1186_1756_8722_6_19 crossref_primary_10_1016_j_yjmcc_2017_06_016 |
| ContentType | Journal Article |
| DBID | FBQ CGR CUY CVF ECM EIF NPM |
| DOI | 10.1096/fj.05-3718com |
| DatabaseName | AGRIS Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed |
| DatabaseTitle | MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) |
| DatabaseTitleList | MEDLINE |
| Database_xml | – sequence: 1 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database – sequence: 3 dbid: FBQ name: AGRIS url: http://www.fao.org/agris/Centre.asp?Menu_1ID=DB&Menu_2ID=DB1&Language=EN&Content=http://www.fao.org/agris/search?Language=EN sourceTypes: Publisher |
| DeliveryMethod | no_fulltext_linktorsrc |
| Discipline | Biology |
| EISSN | 1530-6860 |
| EndPage | 1095 |
| ExternalDocumentID | 15985532 US201301011900 |
| Genre | Research Support, Non-U.S. Gov't Journal Article |
| GroupedDBID | --- -DZ -~X .55 0R~ 0VX 123 18M 1OB 1OC 29H 2WC 33P 34G 39C 3O- 4.4 53G 5GY 5RE 85S AAHHS AAHQN AAMNL AANLZ AAYCA ABCUV ABDNZ ABEFU ABJNI ABOCM ACCFJ ACCZN ACGFS ACIWK ACNCT ACPOU ACPRK ACXQS ACYGS ADKYN ADZMN AEEZP AEIGN AENEX AEQDE AEUYR AFFNX AFFPM AFRAH AFWVQ AGCDD AGHNM AHBTC AI. AITYG AIURR AIWBW AIZAD AJBDE ALMA_UNASSIGNED_HOLDINGS ALUQN ALVPJ AMYDB BFHJK BIYOS C1A CS3 DCZOG DU5 D~5 E3Z EBS EJD F5P F9R FBQ H13 HGLYW HZ~ H~9 J5H L7B LATKE LEEKS MEWTI MVM NEJ O9- OHT OVD Q-A RHI RJQFR ROL SAMSI SJN SUPJJ TEORI TFA TR2 TWZ U18 VH1 W8F WH7 WHG WOQ WXSBR X7M XJT XOL XSW Y6R YBU YCJ YHG YKV YNH YSK Z0Y ZCA ZE2 ZGI ZXP ~KM CGR CUY CVF ECM EIF FRP NPM RHF VXZ Z5M |
| ID | FETCH-LOGICAL-c533M-3b8e8831c63f83d0102c6a55b6c9a103e81426d059ec4603fdaf6a24393397a32 |
| ISSN | 0892-6638 |
| IngestDate | Wed Feb 19 01:51:43 EST 2025 Thu Apr 03 09:44:26 EDT 2025 |
| IsDoiOpenAccess | false |
| IsOpenAccess | true |
| IsPeerReviewed | true |
| IsScholarly | true |
| Issue | 9 |
| Language | English |
| LinkModel | OpenURL |
| MergedId | FETCHMERGED-LOGICAL-c533M-3b8e8831c63f83d0102c6a55b6c9a103e81426d059ec4603fdaf6a24393397a32 |
| OpenAccessLink | https://faseb.onlinelibrary.wiley.com/doi/pdfdirect/10.1096/fj.05-3718com?download=true |
| PMID | 15985532 |
| PageCount | 8 |
| ParticipantIDs | pubmed_primary_15985532 fao_agris_US201301011900 |
| PublicationCentury | 2000 |
| PublicationDate | July 2005 |
| PublicationDateYYYYMMDD | 2005-07-01 |
| PublicationDate_xml | – month: 07 year: 2005 text: July 2005 |
| PublicationDecade | 2000 |
| PublicationPlace | United States |
| PublicationPlace_xml | – name: United States |
| PublicationTitle | The FASEB journal |
| PublicationTitleAlternate | FASEB J |
| PublicationYear | 2005 |
| SSID | ssj0001016 |
| Score | 2.4029498 |
| Snippet | Mitochondrial oxidative damage contributes to a wide range of pathologies, including cardiovascular disorders and neurodegenerative diseases. Therefore,... |
| SourceID | pubmed fao |
| SourceType | Index Database Publisher |
| StartPage | 1088 |
| SubjectTerms | Animals Antioxidants - pharmacology Cytochromes c - secretion Heart - drug effects Heart - physiology Male Mitochondria - drug effects Mitochondria - metabolism Myocardial Reperfusion Injury - pathology Myocardial Reperfusion Injury - physiopathology Myocardial Reperfusion Injury - prevention & control Organophosphorus Compounds - pharmacology Oxygen Consumption - drug effects Protective Agents - pharmacology Rats Rats, Wistar Ubiquinone - analogs & derivatives Ubiquinone - pharmacology |
| Title | Targeting an antioxidant to mitochondria decreases cardiac ischemia-reperfusion injury |
| URI | https://www.ncbi.nlm.nih.gov/pubmed/15985532 |
| Volume | 19 |
| hasFullText | |
| inHoldings | 1 |
| isFullTextHit | |
| isPrint | |
| link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1ba9swFBa9MOhL2db7tqKHvgV1lhWr9mM7WkohZaNN6VuQZakkUKfkAut-fT9Jru10LayDoBiHyELn89F3js45IuRA5FykUhqmktiwrhKcgTcbJrXG8qRioZRLTu5dyvN-9-I2uW3KE_jskll-qP-8mlfyP1LFPcjVZcm-Q7J1p7iBa8gXLSSM9t9k7MO4Q5ohPnjQ72GBb0co7_GqQrWVBcbRKTw5nBpfiRqI0J0hrFpzP1RsYh7MxM6nIeZxNF9MkXYoOju-Oj3ptAcU9vcDlG6Gzu2PZ1w0ymziDzYMznkFRd64Yl3gqhnPp3WsyWPZ-GN9xG4TZVn98OySSOrw1VpzZTEDlUkX1GzWglPW0pk8Cgf7Vesvj8Kpm3_pdhhbTiCjQ7d3jyW1ktuLctn9q9htxnJXyy6KlskyzAdX_fPkV71AO4eFNy6qUValV9H_94XeQTesGr-wNzzvuP5I1iuDgR4H6X8iS6b8TD6EI0QfN8hNjQGqStrCAJ2NaRsDtMYArTBAX8MADRjYJP2z0-sf56w6K4NpEPYeE3lq0lRwLYVNReEqBWqpkiSXOlM8Eibl4GIFyLTRXRkJWygrVQw6KsBIlYi3yEo5Ls0OoSAzOi90BjKZd7k9AieHlRsnNsvyo4LbXbKDaRmoO2BpsDjdu2Q7zNXgIdRKGYAtp0ki4r23__SFrDUg-kpWLd5O8w1Ub5bve8GhvfzZewJ6WVO2 |
| linkProvider | FAO Food and Agriculture Organization of the United Nations |
| openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Targeting+an+antioxidant+to+mitochondria+decreases+cardiac+ischemia-reperfusion+injury&rft.jtitle=The+FASEB+journal&rft.au=Adlam%2C+Victoria+J&rft.au=Harrison%2C+Joanne+C&rft.au=Porteous%2C+Carolyn+M&rft.au=James%2C+Andrew+M&rft.date=2005-07-01&rft.issn=0892-6638&rft.volume=19&rft.issue=9&rft.spage=1088&rft.epage=1095&rft_id=info:doi/10.1096%2Ffj.05-3718com&rft.externalDocID=US201301011900 |
| thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0892-6638&client=summon |
| thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0892-6638&client=summon |
| thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0892-6638&client=summon |